Showing results (101-110 of 225) with videos related to
Sort By:
Pageof 23
The Annals of Pharmacotherapy|March 4, 2010
Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patientMatthieu Roustit, Emeline Blondel, Céline Villier, et al.European Journal of Clinical Pharmacology|October 25, 2022
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series studyAmandine Gouverneur, Jérôme Avouac, Clément Prati, et al.Prostaglandins & Other Lipid Mediators|November 24, 2005
Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometryGaëlle Hardy, Robert Boizel, Janine Bessard, et al.Free Radical Research|December 14, 2006
Biologically active oxidized lipids (phytoprostanes) in the plant diet and parenteral lipid nutritionKathrin Karg, Verena M Dirsch, Angelika M Vollmar, et al.Therapie|January 25, 2007
[Evolution of the satisfaction of subjects enrolled in clinical studies]Adeline Paris, Jean-Luc Bosson, Muriel Salvat Melis, et al.VASA. Zeitschrift Fur Gefasskrankheiten|February 7, 2020
Fluorescence angiography compared to toe blood pressure in the evaluation of severe limb ischemiaChristophe Seinturier, Sophie Blaise, Théophile Tiffet, et al.Therapie|March 25, 2006
[Satisfaction of subjects enrolled in clinical studies]Laure Huot, Adeline Paris, Jean-Luc Bosson, et al.Journal of Cardiovascular Pharmacology|June 27, 2003
Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veinsAhmed Hakim, Françoise Stanke-Labesque, Pascale Hoffmann, et al.Journal of Hypertension|June 14, 2008
EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR studyOlivier Ormezzano, Jean-Luc Cracowski, Jean-Louis Quesada, et al.Thrombosis and Haemostasis|May 26, 2012
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteersRaphael Marlu, Enkelejda Hodaj, Adeline Paris, et al.Pageof 23